Skip to content

Publications on Justice in Health Care (popular)

Health Impact Fund: video highlight of Carnegie Council's "ETHICS MATTER: A Conversation with Thomas Pogge"

India’s stand TRIPS vaccine inequity,” authored with Sachin Chaturvedi, Financial Express, June 8, 2022.

Avoiding Global Pandemic Injustice,” authored with Natasha Chilundika, UTAFITI Journal of African Perspectives, Vol. 17, No. 1, 2022, 23–39.

Equitable Access to Innovative Pharmaceuticals” in Policies for Equitable Access to Health, April 13, 2022.

Replacing Monopolies with Impact Rewards” for United Nation’s World Philosophy Day 2021 Conference at University of Dar Es Salaam, November 18, 2021.

Fake equality, waiver and solutions,” authored with Kevin Lee, The Korea Times, August 15, 2021.

Solving global vaccine inequity requires new incentives for pharmaceutical companies,” authored with Abraar Karan, The BMJ Opinion, April 2, 2021.

A right time to shift pharma gears,” authored with Felicitas Holzer, The Hindu Comment, June 6, 2020, also available at

Restructuring pharmaceutical innovation,” authored with Peggy Tse, CGTN Opinion, June 2, 2020.

COVID-19 and beyond: how to pay for new pharmaceuticals,” authored with Felicitas Holzer and Aidan Hollis, Journal of Medical Ethics Blog, May 25, 2020.

The Health Impact Fund: learning from COVID-19,” authored with Felicitas Holzer, DSA Ireland, 17 April 2020.    German  Chinese  Spanish

Ebola and the need for restructuring pharmaceutical incentives,” authored with Abraar Karan, Journal of Global Health, Volume 5, Issue 1, published online February 11, 2015.

What The EU Could Do To Eradicate Ebola,” Social Europe, January 6, 2015.

The Health Impact Fund: a new paradigm in pharmaceutical innovation” in Contributions to Science 10/1 (2014), 23–28.

The Health Impact Fund: a Mechanism to Improve Access, Innovation and Delivery of Medicines” in Policies for Equitable Access to Health, March 20, 2014.

Medicines for the World” in Policies for Equitable Access to Health, June 3, 2013.

A cure for all ills of the pharmaceutical benefits scheme,” authored with Danielle Celermajer, in Sydney Morning Herald, March 7, 2012.

A Response From The Authors Of The Health Impact Fund” in Intellectual Property Watch, October 3, 2011.

The Health Impact Fund: a better way to reward new medicines” in On the Human – a project of the National Humanities Center, September 4, 2011.

“Making an impact,” authored with Olav Gjelsvik, in Public Service Review: European Science & Technology, issue 10, pp. 206–207, 23 May 2011.

How the poor can pay for life-saving medicines” in The Guardian, Global development, Poverty matters blog, April 7, 2011.

A novel idea to spur life-saving drugs,” OpEd with Peter Lindsay, in Atlantic Journal Constitution, Tuesday, September 21, 2010.

Making malaria pills profitable” in University Post, University of Copenhagen, July 20, 2010.

“Innovative Health Impact Fund aims to save lives,” authored with Sinead Deery and Aidan Hollis, in Edmonton Journal, Saturday, January 30, 2010.

“The Health Impact Fund,” an exchange of views with Pfizer Executive Managing Director Philip Hedger, in Providing Medicines For The Poor, Chemical and Engineering News 86/48 (December 2008), 33–40.

The Health Impact Fund: Boosting Innovation Without Obstructing Free Access,” The AstraZeneca Lecture of 2008 EPHAR (The Federation of European Pharmacological Societies) Congress, Manchester, England, UK, July 17, 2008; abstract in Fundamental & Clinical Pharmacology Volume 22, Issue Supplement s2, August 2008, p. 4.

A Prescription for Change” in RSA Journal 154/5529 (June 2007) 45–47.

A New Approach to Pharmaceutical Innovations,” posted 21 June 2005.

From New York City” (On a Right to Die) in Palliative Medicine 17:2 (March 2003), 119.   Spanish












Skip to toolbar